Share on StockTwits

Fibrocell Science (NASDAQ:FCSC) Director Christine St.Clare purchased 10,000 shares of the company’s stock in a transaction dated Thursday, June 5th. The stock was purchased at an average price of $3.00 per share, with a total value of $30,000.00. Following the completion of the acquisition, the director now directly owns 10,000 shares of the company’s stock, valued at approximately $30,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Fibrocell Science (NASDAQ:FCSC) traded up 14.38% on Friday, hitting $3.34. 381,022 shares of the company’s stock traded hands. Fibrocell Science has a one year low of $2.70 and a one year high of $7.20. The stock has a 50-day moving average of $3.25 and a 200-day moving average of $4.39. The company’s market cap is $136.5 million.

Fibrocell Science (NASDAQ:FCSC) last released its earnings data on Monday, May 19th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by $0.20. Analysts expect that Fibrocell Science will post $-0.80 EPS for the current fiscal year.

Fibrocell Science, Inc is an aesthetic and therapeutic development stage biotechnology company focused on developing novel skin and tissue rejuvenation products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.